Cancer Institute A national cancer institute
designated cancer center

Department: Stanford Cancer Institute

Lymphoma and Hodgkins Disease

  • Saul A. Rosenberg, MD, Professor of Lymphoma
    Member, Stanford Cancer Institute
    Clinical Focus
    • Lymphoma
    • Burkitt's Lymphoma
    • Hodgkin's Disease
    Research Interest

    Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.

    The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.

  • Assistant Professor of Medicine (Oncology)
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Clinical Focus
    • Lymphoma
    • Lymphoma
    • B-Cell Chronic Lymphocytic Leukemia
    Research Interest

    My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

    Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

  • Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Lymphoma
    • Sarcoma
    • Soft Tissue Sarcoma
    Research Interest

    Giant cell tumor of the bone
    Gastrointestinal stromal tumors
    Soft tissue sarcoma
    Osteosarcoma

  • Professor of Radiation Oncology at Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Cutaneous (Dermatologic) Oncology
    • Radiation Oncology
    • Urologic Oncology
    Research Interest

    Outcomes of radiation treatment for prostate cancer. Clinical research interests in the late effects of radiation on normal tissues and chemical modification of radiation injury. Hodgkins's disease and late effects of radiation and combined modality therapy. Radiation sensitizers. Hypoxic cell cytotoxins. Esophageal cancers.
    General adult and pediatric radiation therapy.

  • Professor of Structural Biology
    Member, Bio-X
    Member, Stanford Cancer Institute
    Research Interest

    The Jardetzky laboratory is studying the structures and mechanisms of macromolecular complexes important in viral pathogenesis, allergic hypersensitivities and the regulation of cellular growth and differentiation, with an interest in uncovering novel conceptual approaches to intervening in disease processes. Ongoing research projects include studies of paramyxovirus and herpesvirus entry mechanisms, IgE-receptor structure and function and TGF-beta ligand signaling pathways.

  • The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Cutaneous (Dermatologic) Oncology
    • Cutaneous Lymphoma
    • Cutaneous Lymphoma - Dermatology
    Research Interest

    Clinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.

  • Robert K. and Helen K. Summy Professor in the School of Medicine
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Lymphoma
    • Lymphoma
    • Non-Hodgkin's Lymphoma
    Research Interest

    Clinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.

  • Professor (Research) of Medicine (Oncology)
    Member, Bio-X
    Member, Stanford Cancer Institute
    Research Interest

    Our research focuses on the mechanism of action of tetraspanins, an evolutionary conserved, widely expressed multi-gene family. We study a prototype, CD81, a molecule implicated in the pathogenesis of two major human diseases: hepatitis C virus (HCV) and malaria.

  • Lydia J. Lee Professor in Pediatric Cancer
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Clinical Focus
    • Hematology/Oncology/Stem Cell Transplant, Pediatric
    • Pediatric Hematology-Oncology
    Research Interest

    Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease.

  • Professor of Pathology at Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Hematopathology
    • Pathology and Laboratory Medicine
    • Anatomic Pathology
    Research Interest

    My research interests focus on the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia.

  • Rachford and Carlota Harris Professor
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Research Interest

    Dr. Nolan's group uses high throughput single cell analysis technology of kinase driven signaling cascades to interrogate autoimmunity, cancer, virology (influenza), bacterial pathogens as well as understanding normal immune system function. Using advanced flow cytometric techniques such as Mass Cytometry and computational biology approaches, we focus on high throughput drug screening, mouse models of disease in patient materials, and understanding disease processes at the single cell level.

  • Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus
    Member, Stanford Cancer Institute
    Clinical Focus
    • Lymphoma
    • Hodgkin's Disease
    • Hodgkin's Disease - Hematology
    Research Interest

    Clinical Interests: Hodgkin's disease and non-Hodgkin's lymphomas Research Interests: clinical trials, clinical-pathological-biological correlations

  • James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
    Member, Bio-X
    Member, Stanford Cancer Institute
    Faculty Fellow, Stanford ChEM-H
  • Professor of Surgery (General Surgery) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Breast Cancer
    • Breast Cancer  > Breast Cancer Clinical Trials
    • Breast Cancer
    Research Interest

    Clinical trials in operative procedures such as Nipple-sparing mastectomy, arm lymphatic mapping, skin perfusion and Treatments for Breast Cancer, especially local recurrence. Dr. Wapnir is institutional Principal Investigator and Chair for National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Laboratory and translational research includes exploring the activity of breast iodide transporter in breast cancer brain metastasis.

  • Ronald F. Dorfman, M.B.B.ch., FRCPath, Professor in Hematopathology, Emeritus
    Member, Stanford Cancer Institute
    Clinical Focus
    • Anatomic/Clinical Pathology
    • Pathology and Laboratory Medicine
    Research Interest

    As an Emeritus Professor, I no longer have a research laboratory and devote my half-time effort to lymphoma diagnosis and teaching. I do devote a small amount of effort to lymphoma research in collaboration with Yaso Natkunam and others in the Department of Pathology.

  • Assistant Professor of Medicine (Blood and Marrow Transplantation) and, by courtesy, of Dermatology at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Blood and Marrow Transplant
    • Lymphoma
    • Cutaneous T-Cell Lymphoma
    Research Interest

    My research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.

  • Professor of Pathology and of Medicine (Hematology) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Hematology
    • Hematology
    • Pathology
    Research Interest

    Our laboratory focuses on translational research in 2 main areas - genomic approaches to diagnosis and minimal residual disease testing for patients with cancer, and molecular basis of disorders of thrombosis and hemostasis. My clinical focus is in diagnosis and treatment of disorders of hemostasis and thrombosis and general hematology.

Stanford Medicine Resources:

Footer Links: